Know Cancer

or
forgot password

Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens


N/A
17 Years
90 Years
Open (Enrolling)
Both
Tuberculosis, Lung Cancer

Thank you

Trial Information

Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens


Inclusion Criteria:



- Health group: between 17 to 90 years old

- Tuberculosis group: people who are tuberculosis or lung cancer patients and between
17 to 90 years old

Exclusion Criteria:

- Women subjects are before or after the period within two days

Type of Study:

Observational

Study Design:

Observational Model: Case Control, Time Perspective: Prospective

Principal Investigator

Kuo-Sheng Hung

Investigator Role:

Principal Investigator

Investigator Affiliation:

Taipei Medical University WanFang Hospital

Authority:

Taiwan: Department of Health

Study ID:

99042

NCT ID:

NCT01322685

Start Date:

July 2010

Completion Date:

June 2011

Related Keywords:

  • Tuberculosis
  • Lung Cancer
  • Tuberculosis
  • Lung cancer
  • Lung Neoplasms
  • Tuberculosis

Name

Location